Med. praxi. 2013;10(10):340-343

Calcium - bone and cardiovascular effects

MUDr.Mária Rašková, Ph.D.
3. interní klinika 1. LF UK a VFN v Praze

Calcium and vitamin D play an important role in primary prevention of osteoporosis and secondary prevention of fractures (1). In adults,

calcium is important to maintain the bone mass. Lack of calcium leads to secondary hyperparathyroidism associated with increased bone

loss. Prolonged severe calcium and vitamin D deficiency can lead to the development of osteomalacia. Recent studies have suggested

an increased cardiovascular risk in long-term supplementation with higher doses of calcium, especially for those with sufficient dietary

calcium intake (total intake of 1 400 mg of elemental calcium daily) (2). It is advisable to pay attention to the average daily intake of dietary

calcium in subjects who are considering supplementation with calcium supplements. Calcium supplementation is indicated in patients

with inadequate dietary calcium intake, especially in the case of intolerance or insufficient intake of dairy products. The following article

provides an overview of the known effects and risks of calcium supplementation.

Keywords: calcium, osteoporosis, cardiovascular risk, fractures

Published: November 7, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rašková M. Calcium - bone and cardiovascular effects. Med. praxi. 2013;10(10):340-343.
Download citation

References

  1. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1 992; 327: 1637-1642. Go to original source... Go to PubMed...
  2. Michaëlsson K, Melhus H, Warensjö Lemming E, et al. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ 2013; 346: f228. Go to original source... Go to PubMed...
  3. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1 988-1 994). NCHS Data Brief 2011; 61: 1-8.
  4. Mangano KM, Walsh SJ, Insogna KL, et al. Calcium intake in the United States from dietary and supplemental sources across adult age groups: new estimates from the National Health and Nutrition Examination Survey 2003-2006. J Am Diet Assoc 2011; 111: 687-6 95. Go to original source... Go to PubMed...
  5. Bayer M, Jeníček J, Kučerová I, et al. Doporučené postupy pro diagnostiku a terapii postmenopauzální osteoporózy II, část první. Osteologický bulletin 2007; 2: 74-81.
  6. Yacowitz H, Fleischman AI, Bierenbaum ML. Effects of oral calcium uponserum lipids in man. Br Med J 1 965; 1: 1352-1354. Go to original source... Go to PubMed...
  7. Reid IR, Ames R, Mason B, et al. Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr 2010; 1: 131-139. Go to original source... Go to PubMed...
  8. Atchison DK, Beierwaltes WH. The influence of extracellular and intracellular calcium on the secretion of renin. Pflugers Arch 2013; 465: 5 9-6 9. Go to original source... Go to PubMed...
  9. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483. Go to original source... Go to PubMed...
  10. Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441. Go to original source... Go to PubMed...
  11. Russo D, Miranda I, Ruocco C, et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007; 72: 1255-1261. Go to original source... Go to PubMed...
  12. Bolland MJ, Barber PA, Doughty RN, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008; 336: 262-266. Go to original source... Go to PubMed...
  13. Bolland MJ, Grey A, Avenell A, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: 2040. Go to original source... Go to PubMed...
  14. Green JH, Booth C, Bunning R. Postprandial metabolic responses to milk enriched with milk calcium are different from responses to milk enriched with calcium carbonate. Asia Pac J Clin Nutr 2003; 12: 10 9-11 9.
  15. Lind L, Skarfors E, Berglund L, et al. Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 1997; 50: 967-973. Go to original source... Go to PubMed...
  16. Jorde R, Sundsfjord J, Fitzgerald P, et al. Serum calcium and cardiovascular risk factors and diseases: the Troms? study. Hypertension 1999; 34: 484-4 90. Go to original source... Go to PubMed...
  17. Foley RN, Collins AJ, Ishani A, et al. Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008; 156: 556-563. Go to original source... Go to PubMed...
  18. Nilsson IL, Yin L, Lundgren E, et al. Clinical presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 2002; 17(Suppl 2): N68-74. Go to PubMed...
  19. Vestergaard P, Mollerup CL, Fr?kjaer VG, et al. Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 2003; 27: 216-22. Go to original source... Go to PubMed...
  20. Vervloet MG, van Ittersum FJ, Büttler RM, et al. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. J Am Soc Nephrol 2011; 6: 383-389. Go to original source... Go to PubMed...
  21. Kendrick J, Cheung AK, Kaufman JS, et al. FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol 2011; 22: 1 913-1 922. Go to original source... Go to PubMed...
  22. Faul C, Amaral AP, Oskouei B, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 43 93-4408. Go to original source...
  23. Mirza MA, Larsson A, Melhus H, et al. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 200 9; 207: 546-551.
  24. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956. Go to original source... Go to PubMed...
  25. Sambrook P, Cooper C. Osteoporosis. Lancet 2006; 367: 2010-2018. Go to original source... Go to PubMed...
  26. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med 1997; 103: 12-17. Go to original source... Go to PubMed...
  27. Fraser WD. Hyperparathyroidism. Lancet 200 9; 374: 145-158.
  28. Hagström E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 200 9; 119: 2765-2771. Go to original source... Go to PubMed...
  29. Peiris AN, Youssef D, Grant WB. Secondary hyperparathyroidism: benign bystander or culpable contributor to adverse health outcomes? South Med J 2012; 105: 36-42. Go to original source... Go to PubMed...
  30. Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002; 23: 552-559. Go to original source... Go to PubMed...
  31. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 2 93: 2257-2264. Go to original source... Go to PubMed...
  32. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007; 92: 1415-1423. Go to original source... Go to PubMed...
  33. Grant AM, Avenell A, Campbell MK, on behalf of the RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621-1628. Go to original source... Go to PubMed...
  34. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 66 9-683. Go to original source... Go to PubMed...
  35. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13: 257-264. Go to original source... Go to PubMed...
  36. Christgau S. Circadian variation in serum CrossLaps concentration is reduced in fasting individuals. Clin Chem 2000; 46: 431. Go to original source...
  37. Grey A, Bolland MJ. The effect of treatments for osteoporosis on mortality.Osteoporos Int 2013; 24: 1-6. Go to original source... Go to PubMed...
  38. Lyles KW, Colón-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture.N Engl J Med 2007; 357: 17 99-180 9. Go to original source... Go to PubMed...
  39. Kocián J, Patlejchová E. Dieta při odvápnění kostí - osteoporóze. Triton 1 998: 151.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.